T2DM Risk in Offspring Greater With T2DM Versus GDM Exposure

Share this content:
T2DM Risk in Offspring Greater With T2DM Versus GDM Exposure
T2DM Risk in Offspring Greater With T2DM Versus GDM Exposure

THURSDAY, June 14, 2018 (HealthDay News) -- In utero exposure to type 2 diabetes is associated with increased risk of type 2 diabetes in offspring versus exposure to gestational diabetes, according to a study published online June 11 in JAMA Pediatrics.

Brandy A. Wicklow, M.D., from the University of Manitoba in Winnipeg, Canada, and colleagues examined the correlation of in utero exposure to gestational diabetes and type 2 diabetes with the development of type 2 diabetes in offspring, stratified by First Nations (FN) status. A pediatric diabetes clinical database was linked to a population-based research data repository; the cohort study included 467,850 offspring.

The researchers found that after adjustment for sex, maternal age, socioeconomic status, birth size, and gestational age, FN status and diabetes exposure were correlated with incident type 2 diabetes in offspring. The risk to offspring was greater with type 2 diabetes exposure versus gestational diabetes exposure (3.19 versus 0.8 cases per 1,000 person-years). Any diabetes exposure was correlated with accelerated time to the development of type 2 diabetes in offspring by a factor of 0.74 and 0.5 for gestational diabetes and type 2 diabetes, respectively, compared with no diabetes exposure. Risk was higher for FN offspring versus non-FN offspring (0.96 versus 0.14 cases per 1,000 person-years). The interactions between FN and type 2 diabetes and FN and gestational diabetes were not significant.

"Important differences exist in offspring risk based on type of diabetes exposure in utero," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »